BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2023 6:38:44 AM | Browse: 236 | Download: 560
 |
Received |
|
2022-10-12 14:44 |
|
Peer-Review Started |
|
2022-10-12 14:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-13 03:28 |
|
Revised |
|
2022-12-13 07:23 |
|
Second Decision |
|
2022-12-30 03:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-01-03 00:53 |
|
Articles in Press |
|
2023-01-03 00:53 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-01-28 06:26 |
|
Publish the Manuscript Online |
|
2023-02-06 06:38 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical and Translational Research |
| Article Title |
CD93 serves as a potential biomarker of gastric cancer and correlates with the tumor microenvironment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zheng Li, Xiao-Jie Zhang, Chong-Yuan Sun, He Fei, Ze-Feng Li and Dong-Bing Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dong-Bing Zhao, MD, Professor, Department of Pancreatic and Gastric Surgical Oncology, National Cancer Center/National Clinical Research for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Pan-jia-yuan South Lane, Chaoyang District, Beijing 100021, China. dbzhao@cicams.ac.cn |
| Key Words |
Gastric cancer; CD93; Tumor microenvironment; Immunotherapy; Prognosis; Biomarker |
| Core Tip |
Gastric cancer (GC) is an aggressive malignancy, with a 5-year survival rate lower than 20%. The disease burden caused by GC remains heavy worldwide. In this study, various analyses were performed using transcriptomic profiles from the Gene Expression Omnibus databases and The Cancer Genome Atlas. Finally, enrichment analysis and protein-protein interaction network were constructed. CD93 is identified as a diagnostic and prognostic biomarker of GC, which is closely related to the immune infiltration in the tumor microenvironment. Then, Immune-related gene modules were identified to further reveal the relationship between CD93 and immune characteristics. |
| Publish Date |
2023-02-06 06:38 |
| Citation |
Li Z, Zhang XJ, Sun CY, Fei H, Li ZF, Zhao DB. CD93 serves as a potential biomarker of gastric cancer and correlates with the tumor microenvironment. World J Clin Cases 2023; 11(4): 738-755 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i4/738.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i4.738 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
